Generali Investments CEE Portfolio holdings
Top Buys
| 1 |
B
Barrick Mining
B
|
+$6.9M |
| 2 |
Microsoft
MSFT
|
+$4.97M |
| 3 |
Dell
DELL
|
+$4.38M |
| 4 |
Broadcom
AVGO
|
+$4.18M |
| 5 |
AstraZeneca
AZN
|
+$2.96M |
Top Sells
| 1 |
iShares Core MSCI Emerging Markets ETF
IEMG
|
+$9.27M |
| 2 |
Viatris
VTRS
|
+$3.22M |
| 3 |
Sasol
SSL
|
+$3.06M |
| 4 |
MSCI
MSCI
|
+$2.58M |
| 5 |
Royal Bank of Canada
RY
|
+$2.25M |
Sector Composition
| 1 | Technology | 10.65% |
| 2 | Financials | 6.27% |
| 3 | Consumer Discretionary | 5.18% |
| 4 | Healthcare | 4.62% |
| 5 | Communication Services | 3.92% |
Similar funds
Generali Investments CEE's Q1 2026 Portfolio in Review
As of Q1 2026, Generali Investments CEE held 462 positions worth $1.91B, up 34% from $1.42B the previous quarter. Its ten largest holdings account for 21% of the portfolio.
Generali Investments CEE deployed $503M of net new capital in Q1 2026, opening 66 new positions and adding to 94 existing holdings. Its largest new stake was AstraZeneca: 15,328 shares worth $2.98M.
By sector, the portfolio is most concentrated in Technology at 11% of assets, down from 15% a quarter earlier, followed by Financials and Consumer Discretionary.
On the sell side, the largest reduction was Viatris, an estimated $3.22M trimmed.
- Generali Investments CEE's largest Q1 2026 buy was AstraZeneca: 15,328 shares worth $2.98M.
- Generali Investments CEE added most to Barrick Mining in Q1 2026, an estimated $6.9M increase.
- Generali Investments CEE's biggest Q1 2026 reduction was Viatris, cutting an estimated $3.22M.
- Generali Investments CEE fully exited iShares Core MSCI Emerging Markets ETF in Q1 2026, selling an estimated $9.27M.
- Generali Investments CEE's ten largest holdings make up 21% of its $1.91B portfolio in Q1 2026.
- Generali Investments CEE opened 66 new positions and closed 10 in Q1 2026.
- Generali Investments CEE's portfolio value rose 34% quarter-over-quarter to $1.91B.
Based on Generali Investments CEE's 13F filing for Q1 2026, filed 15 Apr 2026.